101 related articles for article (PubMed ID: 23020221)
1. Pitfall in the use of terminal deoxynucleotidyl transferase (TdT) in the cytological diagnosis of lymphoma.
Ingoldsby H; Billett P; Leader M
Histopathology; 2013 Jan; 62(2):359-60. PubMed ID: 23020221
[No Abstract] [Full Text] [Related]
2. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma.
Suzumiya J; Ohshima K; Kikuchi M; Takeshita M; Akamatsu M; Tashiro K
J Pathol; 1997 May; 182(1):86-91. PubMed ID: 9227346
[TBL] [Abstract][Full Text] [Related]
3. Terminal deoxynucleotidyl transferase (TdT) negative early T cell precursor acute lymphoblastic leukemia (ETP-ALL) with spontaneous acute kidney injury.
Kidoguchi K; Yokoo M; Umino A; Aoki S; Kimura S
Ann Hematol; 2020 Apr; 99(4):885-886. PubMed ID: 32025838
[No Abstract] [Full Text] [Related]
4. Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall.
Buresh CJ; Oliai BR; Miller RT
Am J Clin Pathol; 2008 Jun; 129(6):894-8. PubMed ID: 18480005
[TBL] [Abstract][Full Text] [Related]
5. [MIC2 (CD99) as a diagnostic marker for TdT-negative B lymphoblastic lymphoma].
Ikeda N; Imao T; Hisano Y; Kamao T; Uno M; Mizushima T
Rinsho Ketsueki; 2023; 64(2):130-132. PubMed ID: 36990733
[TBL] [Abstract][Full Text] [Related]
6. Terminal Deoxynucleotidyl Transferase (TdT)-negative Lymphoblastic Leukemia in Pediatric Patients: Incidence and Clinical Significance.
Yasmeen S; Rajkumar A; Grossman H; Szallasi A
Pediatr Dev Pathol; 2017; 20(6):463-468. PubMed ID: 29187045
[TBL] [Abstract][Full Text] [Related]
7. Terminal deoxynucleotidyl transferase (TdT)-negative T-cell lymphoblastic lymphoma with loss of the T-cell lineage-specific marker CD3 at relapse: a rare entity with an aggressive outcome.
Hassan M; Abdullah HMA; Wahid A; Qamar MA
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29884716
[TBL] [Abstract][Full Text] [Related]
8. [Terminal deoxynucleotidyl transferase in various immunophenotypic cells in leukemia].
Tang YM
Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):544-6, 573-4. PubMed ID: 1338518
[TBL] [Abstract][Full Text] [Related]
9. Unique pattern of nuclear TdT immunofluorescence distinguishes normal precursor B cells (Hematogones) from lymphoblasts of precursor B-lymphoblastic leukemia.
Hurford MT; Altman AJ; DiGiuseppe JA; Sherburne BJ; Rezuke WN
Am J Clin Pathol; 2008 May; 129(5):700-5. PubMed ID: 18426728
[TBL] [Abstract][Full Text] [Related]
10. Terminal deoxynucleotidyl transferase negative B-lymphoblastic leukaemia/lymphoma with CD138 expression.
Lee SY; Hue SS
Pathology; 2020 Feb; 52(2):286-289. PubMed ID: 31883671
[No Abstract] [Full Text] [Related]
11. Absence of terminal deoxynucleotidyl transferase expression in T-ALL/LBL accumulates chromosomal abnormalities to induce drug resistance.
Xiao H; Wang S; Tang Y; Li S; Jiang Y; Yang Y; Zhang Y; Han Y; Wu X; Zheng L; Li Y; Gao Y
Int J Cancer; 2023 Jun; 152(11):2383-2395. PubMed ID: 36757202
[TBL] [Abstract][Full Text] [Related]
12. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections.
Orazi A; Cattoretti G; John K; Neiman RS
Mod Pathol; 1994 Jun; 7(5):582-6. PubMed ID: 7937725
[TBL] [Abstract][Full Text] [Related]
13. [Terminal deoxynucleotidyl transferase (TdT)].
Sasaki R
Nihon Rinsho; 2004 Dec; 62 Suppl 12():815-9. PubMed ID: 15658458
[No Abstract] [Full Text] [Related]
14. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma.
Zhou Y; Fan X; Routbort M; Cameron Yin C; Singh R; Bueso-Ramos C; Thomas DA; Milton DR; Medeiros LJ; Lin P
Mod Pathol; 2013 Oct; 26(10):1338-45. PubMed ID: 23702731
[TBL] [Abstract][Full Text] [Related]
15. Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.
Faber J; Kantarjian H; Roberts MW; Keating M; Freireich E; Albitar M
Arch Pathol Lab Med; 2000 Jan; 124(1):92-7. PubMed ID: 10629138
[TBL] [Abstract][Full Text] [Related]
16. Terminal deoxynucleotidyl transferase negative T-cell lymphoblastic lymphoma in aleukemic patient.
Brčić I; Labar B; Perić-Balja M; Bašić-Kinda S; Nola M
Int J Hematol; 2008 Sep; 88(2):189-191. PubMed ID: 18512118
[TBL] [Abstract][Full Text] [Related]
17. Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia.
Yu CH; Su YH; Jou ST; Lu MY; Lin CY; Lin KH; Chang HH; Chou SW; Huang YH; Lin DT; Lin SW; Chen HY; Chang YH; Yang YL
Pathol Res Pract; 2024 Apr; 256():155287. PubMed ID: 38579576
[TBL] [Abstract][Full Text] [Related]
18. Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.
Ohgami RS; Arber DA; Zehnder JL; Natkunam Y; Warnke RA
Adv Anat Pathol; 2013 May; 20(3):137-40. PubMed ID: 23574769
[TBL] [Abstract][Full Text] [Related]
19. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
Morse EE; Gaffney J; Donskoy E; Pisciotto P; Altman A; Quinn J; Goldschneider I
Ann Clin Lab Sci; 1983; 13(2):128-32. PubMed ID: 6344744
[TBL] [Abstract][Full Text] [Related]
20. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
